Heme degradation and vascular injury

Antioxidants and Redox Signaling

Volumn 12, Issue 2, 2010, Pages 233-248

  Belcher, John D ^a   Beckman, Joan D ^a   Balla, Gyorgy ^b   Balla, Jozsef ^c   Vercellotti, Gregory ^a  

^a Division of Hematology   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 GLOBULIN; BETA GLOBULIN; FERRIC ION; FERRITIN; FERROUS ION; HEME; HEME OXYGENASE 1; HEMIN; HEMOGLOBIN; HEMOPEXIN; HYDROGEN PEROXIDE; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; OXIDIZING AGENT;

APOPTOSIS; ATOM; BLOOD VESSEL INJURY; BLOOD VESSEL OCCLUSION; CATALYSIS; CELL ACTIVATION; CELL PROTECTION; ERYTHROCYTE; HEMOLYSIS; HUMAN; INFLAMMATION; INTRAVASCULAR HEMOLYSIS; ISCHEMIA; LEUKOCYTE; MEMBRANE CHANNEL; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN METABOLISM; REPERFUSION INJURY; REVIEW; SICKLE CELL; SIGNAL TRANSDUCTION; THROMBOCYTE; ANIMAL; BIOLOGICAL MODEL; BLOOD VESSEL; DRUG EFFECT; ENZYME ACTIVATION; INJURY; METABOLISM; MOUSE; OXIDATIVE STRESS; PHYSIOLOGY; SICKLE CELL ANEMIA;

ANIMALIA;

ANEMIA, SICKLE CELL; ANIMALS; BLOOD VESSELS; ENZYME ACTIVATION; HEME; HEME OXYGENASE-1; HEMIN; HEMOGLOBINS; HUMANS; HYDROGEN PEROXIDE; MICE; MODELS, BIOLOGICAL; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 77949496427     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2009.2822     Document Type: Review

References (156)

1. Agarwal A, Kim Y, Matas A, Alam J, and Nath K. Gas-generation systems in acute renal allograft rejection in the rat: co-Induction of heme oxygenase and nitric oxide syn-thase Transplantation 61: 93-98, 1996.
2. Akerström B. Tissue distribution of guinea pig alpha 1-microglobulin. Cell Mol Biol 29: 489-495, 1983.
3. Alam J. Multiple elements within the 5' distal enhancer of the mouse heme oxygenase-1 gene mediate induction by heavy metals. J Biol Chem 269: 25049-25056, 1994.
4. Alam J, Camhi S, and Choi AMK. Identification of a second region upstream of the mouse heme oxygenase-1 gene that functions as a basal level and inducer-dependent transcription enhancer. J Biol Chem 270: 11977-11984, 1995.
5. Alam J and Den Z. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem 267: 21894-21900, 1992.
6. Alam J, Killeen E, Gong P, Naquin R, Hu B, Stewart D, Ingelfinger JR, and Nath KA. Heme activates the heme oxygenase-1 gene in renal epithelial cells by stabilizing Nrf2. Am J Physiol Renal Physiol 284: F743-F752, 2003. (Pubitemid 36336981)
7. Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, Choi AMK, Burow ME, and Tou J-S. Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells: role of p38 kinase and Nrf2 transcription factor. J Biol Chem 275: 27694-27702, 2000.
8. Allhorn M, Berggard T, Nordberg J, Olsson ML, and Akerstrom B. Processing of the lipocalin alpha 1-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99: 1894-1901, 2002. (Pubitemid 34525466)
9. Allhorn M, Klapyta A, and Akerström B. Redox properties of the lipocalin [alpha]1-microglobulin: reduction of cyto-chrome c, hemoglobin, and free iron. Free Radic Biol Med 38: 557-567, 2005. (Pubitemid 40416851)
10. Amer J, Ghoti H, Rachmilewitz E, Koren A, Levin C, and Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants. Br J Haematol 132: 108-113, 2006. (Pubitemid 43381577)
11. Arosio P and Levi S. Ferritin, iron homeostasis, and oxi-dative damage. Free Radic Biol Med 33: 457-463, 2002. (Pubitemid 34874967)
12. Aslan M and Canatan D. Modulation of redox pathways in neutrophils from sickle cell disease patients. Exp Hematol 36: 1535-1544, 2008.
13. Aslan M and Freeman BA. Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease: mechanisms and consequences. Cell Mol Biol (Noisy-le-Grand) 50: 95-105, 2004.
14. Aslan M and Freeman BA. Redox-dependent impairment of vascular function in sickle cell disease. Free Radic Biol Med 43: 1469-1483, 2007. (Pubitemid 47615401)
15. Aslan M, Ryan TM, Adler B, Townes TM, Parks DA, Thompson JA, Tousson A, Gladwin MT, Patel RP, Tarpey MM, Batinic-Haberle I, White CR, and Freeman BA. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proc Natl Acad Sci USA 98: 15215-15220, 2001. (Pubitemid 34013994)
16. Aslan M, Thornley-Brown D, and Freeman BA. Reactive species in sickle cell disease. Ann N Y Acad Sci 899: 375-391, 2000. (Pubitemid 30352801)
17. Bakker GR and Boyer RF. Iron incorporation into apo-ferritin: the role of apoferritin as a ferroxidase. J Biol Chem 261: 13182-13185, 1986. (Pubitemid 17006893)
18. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, and Vercellotti GM. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 267: 18148-18153, 1992.
19. Balla G, Jacob HS, Eaton JW, Belcher JD, and Vercellotti GM. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Ar-terioscler Thromb 11: 1700-1711, 1991.
20. Balla G, Vercellotti G, Muller-Eberhard U, Eaton JW, and Jacob HS. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64: 648-655, 1991.
21. Balla G, Vercellotti GM, Eaton JW, and Jacob HS. Iron loading of endothelial cells augments oxidant damage. J Lab Clin Med 116: 546-554, 1990. (Pubitemid 20336624)
22. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, and Vercellotti GM. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90: 9285-9289, 1993. (Pubitemid 23315768)
23. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, Balla G. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid Redox Signal 9: 1-19, 2007.
24. Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, and Balla G. Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 18: v8-v12, 2003. (Pubitemid 36896440)
25. Bamm VV, Tsemakhovich VA, Shaklai M, and Shaklai N. Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. Biochemistry 43: 3899-3906, 2004. (Pubitemid 38437056)
26. Belcher JD, Bryant CJ, Nguyen J, Bowlin PR, Kielbik MC, Bischof JC, Hebbel RP, and Vercellotti GM. Transgenic sickle mice have vascular inflammation. Blood 101: 3953-3959, 2003. (Pubitemid 36857872)
27. Belcher JD, Mahaseth H, Welch TE, Otterbein LE, Hebbel RP, and Vercellotti GM. Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice. J Clin Invest 116: 808-816, 2006. (Pubitemid 43326890)
28. Belcher JD, Mahaseth H, Welch TE, Vilback AE, Sonbol KM, Kalambur VS, Bowlin PR, Bischof JC, Hebbel RP, and Vercellotti GM. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice. Am J Physiol Heart Circ Physiol 288: H2715-H2725, 2005. (Pubitemid 40720650)
29. Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, and Vercellotti GM. Low-density lipo-protein susceptibility to oxidation and cytotoxicity to en-dothelium in sickle cell anemia. J Lab Clin Med 133: 605-612, 1999. (Pubitemid 29257224)
30. Belcher JD, Marker PH, Weber JP, Hebbel RP, and Vercel-lotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 96: 2451-2459, 2000.
31. Berggard T, Thelin N, Falkenberg C, Enghild JJ, and Akerstrom B. Prothrombin, albumin and immunoglobulin A form covalent complexes with a1-microglobulin in human plasma. Eur J Biochem 245: 676-683, 1997. (Pubitemid 27223901)
32. Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, and Buchanan GR. Beneficial effect of intravenous dexa-methasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 92: 3082-3089, 1998. (Pubitemid 28492313)
33. Bolann B and Ulvik R. On the limited ability of superoxide to release iron from ferritin. Eur J Biochem 193: 899-904, 1990. (Pubitemid 20381724)
34. Bruzzone CM, Belcher JD, Schuld NJ, Newman KA, Vineyard J, Nguyen J, Chen C, Beckman JD, Steer CJ, and Vercellotti GM. Quantitative real-time polymerase chain reaction (qRT-PCR) restriction fragment length polymorphism (RFLP) method for monitoring highly conserved transgene expression during gene therapy. Translat Res 152: 290-297, 2008.
35. Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, Jia Y, Mikolajczyk M, Boretti FS, Schoedon G, Alayash AI, and Schaer DJ. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113: 2578-2586, 2009.
36. Buehler PW, Vallelian F, Mikolajczyk MG, Schoedon G, Schweizer T, Alayash AI, and Schaer DJ. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. Antioxid Redox Signal 10: 1449-1462, 2008.
37. Bunn HF and Jandl JH. Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem 243: 465-475, 1968.
38. Conran N, Saad S, Costa F, and Ikuta T. Leukocyte numbers correlate with plasma levels of granulocyte- macrophage colony-stimulating factor in sickle cell disease. Ann Hematol 86: 255-261, 2007. (Pubitemid 46351400)
39. Davies DM, Smith A, Muller-Eberhard U, and Morgan WT. Hepatic subcellular metabolism of heme from heme-hemopexin: incorporation of iron into ferritin. Biochem Biophys Res Commun 91: 1504-1511, 1979. (Pubitemid 10143651)
40. Elbirt KK, Whitmarsh AJ, Davis RJ, and Bonkovsky HL. Mechanism of sodium arsenite-mediated induction of heme oxygenase-1 in hepatoma cells: role of mitogen-activated protein N kinases. J Biol Chem 273: 8922-8931, 1998. (Pubitemid 28176175)
41. Elion JE, Brun M, Odie'vre M-H, Lapoume' roulie CL, and Krishnamoorthy R. Vaso-occlusion in sickle cell anemia: role of interactions between blood cells and endothelium. Hematol J 5: S195-S198, 2004. (Pubitemid 39077304)
42. Embury SH, Matsui NM, Ramanujam S, Mayadas TN, Noguchi CT, Diwan BA, Mohandas N, and Cheung AT. The contribution of endothelial cell P-selectin to the microvascular flow of mouse sickle erythrocytes in vivo. Blood 104: 3378-3385, 2004. (Pubitemid 39507162)
43. Eyssen-Hernandez R, Ladoux A, and Frelin C. Differential regulation of cardiac heme oxygenase-1 and vascular endo-thelial growth factor mRNA expressions by hemin, heavy metals, heat shock and anoxia. FEBS Lett 382: 229-233, 1996. (Pubitemid 26091437)
44. Fadlon E, Vordermeier S, Pearson TC, Mire-Sluis AR, Du-monde DC, Phillips J, Fishlock K, and Brown KA. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64. Blood 91: 266-274, 1998. (Pubitemid 28018754)
45. Fasano M, Mattu M, Coletta M, and Ascenzi P. The heme-iron geometry of ferrous nitrosylated heme-serum lipo-proteins, hemopexin, and albumin: a comparative EPR study. J Inorgan Biochem 91: 487-490, 2002.
46. Foidart M, Liem HH, Adornato BT, Engel WK, and Muller-Eberhard U. Hemopexin metabolism in patients with altered serum levels. J Lab Clin Med 102: 838-846, 1983. (Pubitemid 14228276)
47. Foresti R, Clark JE, Green CJ, and Motterlini R. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells. involvement of superoxide and peroxynitrite anions. J Biol Chem 272: 18411-18417, 1997. (Pubitemid 27306435)
48. Gburek J, Verroust PJ, Willnow TE, Fyfe JC, Nowacki W, Jacobsen C, Moestrup SK, and Christensen EI. Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol 13: 423-430, 2002. (Pubitemid 34110430)
49. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19: 1807-1819, 2007. (Pubitemid 47090178)
50. Graca-Souza AV, Arruda MAB, de Freitas MS, Barja-Fidalgo C, and Oliveira PL. Neutrophil activation by heme: implications for inflammatory processes. Blood 99: 4160-4165, 2002. (Pubitemid 35332061)
51. Griffin TC, McIntire D, and Buchanan GR. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N Engl J Med 330: 733-737, 1994. (Pubitemid 24080218)
52. Grinshtein N, Bamm VV, Tsemakhovich VA, and Shaklai N. Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron. Biochemistry 42: 6977-6985, 2003. (Pubitemid 36706480)
53. Guaeye PM, Glasser N, Faerard G, and Lessinger J-M. Influence of human haptoglobin polymorphism on oxidative stress induced by free hemoglobin on red blood cells. Clin Chem Lab Med 44: 542-547, 2006. (Pubitemid 43735624)
54. Halliwell B and Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219: 1-14, 1984. (Pubitemid 14171443)
55. Hartsfield CL, Alam J, and Choi AMK. Differential signaling pathways of HO-1 gene expression in pulmonary and systemic vascular cells. Am J Physiol Lung Cell Mol Physiol 277: L1133-L1141, 1999. (Pubitemid 30046040)
56. Hebbel RP and Vercellotti GM. The endothelial biology of sickle cell disease. J Lab Clin Med 129: 288-293, 1997. (Pubitemid 27169430)
57. Higashimoto Y, Sato H, Sakamoto H, Takahashi K, Palmer G, and Noguchi M. The reactions of heme- and verdoheme-heme oxygenase-1 complexes with FMN-depleted NADPH-cytochrome P450 reductase: electrons required for verdoheme oxidation can be transferred through a pathway not involving FMN. J Biol Chem 281: 31659-31667, 2006. (Pubitemid 46041430)
58. Hofstra TC, Kalra VK, Meiselman HJ, and Coates TD. Sickle erythrocytes adhere to polymorphonuclear neutro-phils and activate the neutrophil respiratory burst. Blood 87: 4440-4447, 1996. (Pubitemid 26152286)
59. Huang K-T, Han TH, Hyduke DR, Vaughn MW, Van Herle H, Hein TW, Zhang C, Kuo L, and Liao JC. Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci USA 98: 11771-11776, 2001. (Pubitemid 32928804)
60. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, and Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood 106: 2572-2579, 2005. (Pubitemid 41510836)
61. Immenschuh S, Kietzmann T, Hinke V, Wiederhold M, Katz N, and Muller-Eberhard U. The rat heme oxygenase-1 gene is transcriptionally induced via the protein kinase a signaling pathway in rat hepatocyte cultures. Mol Pharmacol 53: 483-491, 1998. (Pubitemid 28162871)
62. Ishikawa M, Numazawa S, and Yoshida T. Redox regulation of the transcriptional repressor Bach1. Free Radic Biol Med 38: 1344-1352, 2005. (Pubitemid 40602836)
63. Ivics Z, Hackett PB, Plasterk RH, and Izsvak Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 91: 501-510, 1997. (Pubitemid 27508239)
64. Janssen Y, Van Houten B, Borm P, and Mossman B. Cell and tissue responses to oxidative damage. Lab Invest. 69: 261-274, 1993. (Pubitemid 23315710)
65. Jay U. Methemoglobin: it's not just blue: a concise review. Am J Hematol 82: 134-144, 2007.
66. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, and Balla G. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100: 879-887, 2002. (Pubitemid 34832613)
67. Juckett MB, Balla J, Balla G, Jessurun J, Jacob HS, Vercellotti GM. Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 147: 782-789, 1995.
68. Kalambur VS, Mahaseth H, Bischof JC, Kielbik MC, Welch TE, Vilback A, Swanlund DJ, Hebbel RP, Belcher JD, and Vercellotti GM. Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy. Am J Hematol 77: 117-125, 2004. (Pubitemid 39281854)
69. Kato GJ and Gladwin MT. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA 300: 2638-2646, 2008.
70. Kaul DK and Hebbel RP. Hypoxia=reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 106: 411-420, 2000. (Pubitemid 30655641)
71. Kaul DK, Liu XD, Choong S, Belcher JD, Vercellotti GM, and Hebbel RP. Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. Am J Physiol Heart Circ Physiol 287: H293-H301, 2004. (Pubitemid 38802365)
72. Kawashima A, Oda Y, Yachie A, Koizumi S, and Nakanishi I. Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33: 125-130, 2002. (Pubitemid 34112962)
73. Keyse SM and Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci USA 86: 99-103, 1989. (Pubitemid 19036341)
74. Kitamuro T, Takahashi K, Ogawa K, Udono-Fujimori R, Takeda K, Furuyama K, Nakayama M, Sun J, Fujita H, Hida W, Hattori T, Shirato K, Igarashi K, and Shibahara S. Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J Biol Chem 278: 9125-9133, 2003. (Pubitemid 36800393)
75. Krajewski ML, Hsu LL, and Gladwin MT. The proverbial chicken or the egg? dissection of the role of cell-free hemoglobin versus reactive oxygen species in sickle cell pathophysiology. Am J Physiol Heart Circ Physiol 295: H4-H7, 2008.
76. Krishna MC, Grahame DA, Samuni A, Mitchell JB, and Russo A. Oxoammonium cation intermediate in the nitroxide-catalyzed dismutation of superoxide. Proc Natl Acad Sci USA 89: 5537-5541, 1992.
77. Krishna MC, Samuni A, Taira J, Goldstein S, Mitchell JB, and Russo A. Stimulation by nitroxides of catalase-like activity of hemeproteins: kinetics and mechanism. J Biol Chem 271: 26018-26025, 1996. (Pubitemid 26347440)
78. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman H-J, Law SKA, and Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 409: 198, 2001.
79. Kumar S and Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. Toxicol Lett 157: 175-188, 2005. (Pubitemid 40726102)
80. Kurata S, Matsumoto M, and Nakajima H. Transcriptional control of the heme oxygenase gene in mouse M1 cells during their TPA-induced differentiation into macro-phages. J Cell Biochem 62: 314-324, 1996. (Pubitemid 26301531)
81. Kurata S-C, Matsumoto M, Hoshi M, and Nakajima H. Transcriptional control of the heme oxygenase gene during mouse spermatogenesis. Eur J Biochem 217: 633-638, 1993. (Pubitemid 23311974)
82. Kurata S-I, Matsumoto M, Tsuji Y, and Nakajima H. Li-popolysaccharide activates transcription of the heme oxy-genase gene in mouse M1 cells through oxidative activation of nuclear factor kB. Eur J Biochem 239: 566-571, 1996. (Pubitemid 26253072)
83. Lard LR, Mul FP, de Haas M, Roos D, and Duits AJ. Neutrophil activation in sickle cell disease. J Leukoc Biol 66: 411-415, 1999. (Pubitemid 29439247)
84. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, and Abraham NG. Identification of binding sites for transcription factors NF-{kappa}B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 91: 5987-5991, 1994. (Pubitemid 24188267)
85. Lee PJ, Jiang B-H, Chin BY, Iyer NV, Alam J, Semenza GL, and Choi AMK. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997. (Pubitemid 27102353)
86. Leonard SS, Harris GK, and Shi X. Metal-induced oxidative stress and signal transduction. Free Radic Biol Med 37: 1921- 1942, 2004. (Pubitemid 39491314)
87. Levi S and Arosio P. Mitochondrial ferritin. Int J Biochem Cell Biol 36: 1887-1889, 2004. (Pubitemid 38760019)
88. Levi S, Luzzago A, Cesareni G, Cozzi A, Franceschinelli F, Albertini A, and Arosio P. Mechanism of ferritin iron uptake: activity of the H-chain and deletion mapping of the ferro-oxidase site: a study of iron uptake and ferro-oxidase activity of human liver, recombinant H-chain ferritins, and of two H-chain deletion mutants. J Biol Chem 263: 18086-18092, 1988. (Pubitemid 19005083)
89. Lin F and Girotti AW. Elevated ferritin production, iron containment, and oxidant resistance in hemin-treated leukemia cells. Arch Biochem Biophys 346: 131-141, 1997. (Pubitemid 27415304)
90. Lin JHC, Villalon P, Martasek P, and Abraham NG. Regulation of heme oxygenase gene expression by cobalt in rat liver and kidney. Eur J Biochem 192: 577-582, 1990. (Pubitemid 20316857)
91. Logdberg LE, Akerstrom B, and Badve S. Tissue distribution of the lipocalin alpha-1 microglobulin in the developing human fetus. J Histochem Cytochem 48: 1545-1552, 2000.
92. Lu TH, Shan Y, Pepe J, Lambrecht RW, and Bonkovsky HL. Upstream regulatory elements in chick heme oxygenase-1 promoter: a study in primary cultures of chick embryo liver cells. Mol Cell Biochem 209: 17-27, 2000. (Pubitemid 30451431)
93. Lum H and Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280: C719-C741, 2001.
94. Mahaseth H, Vercellotti GM, Welch TE, Bowlin PR, Sonbol KM, Hsia CJ, Li M, Bischof JC, Hebbel RP, and Belcher JD. Polynitroxyl albumin inhibits inflammation and vasooc-clusion in transgenic sickle mice. J Lab Clin Med 145: 204-211, 2005. (Pubitemid 40692403)
95. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517-554, 1997. (Pubitemid 27238886)
96. Martinek RG. Improved micro-method for determination of serum bilirubin. Clin Chim Acta 13: 161-170, 1966.
97. Mense SM and Zhang L. Heme: a versatile signaling molecule controlling the activities of diverse regulators ranging from transcription factors to MAP kinases. Cell Res 16: 681-692, 2006. (Pubitemid 44258921)
98. Minneci PC, Deans KJ, Zhi H, Yuen PS, Star RA, Banks SM, Schechter AN, Natanson C, Gladwin MT, and Solomon SB. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxy-hemoglobin. J Clin Invest 115: 3409-3417, 2005. (Pubitemid 43121829)
99. Misra UK, Sharma T, and Pizzo SV. Ligation of cell surface-associated glucose-regulated protein 78 by receptor-recognized forms of {alpha}2-macroglobulin: activation of p21-activated protein kinase-2-dependent signaling in murine peritoneal macrophages. J Immunol 175: 2525-2533, 2005. (Pubitemid 41113864)
100. Motterlini R, Foresti R, Intaglietta M, and Winslow RM. NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol Heart Circ Physiol 270: H107-H114, 1996.
101. Muller-Eberhard U, Javid J, Liem HH, Hanstein A, and Hanna M. Brief report: plasma concentrations of hemo-pexin, haptoglobin and heme in patients with various he-molytic diseases. Blood 32: 811-815, 1968.
102. Murphy B, Laderoute K, Short S, and Sutherland R. The identification of heme oxygenase as a major hypoxic stress protein in Chinese hamster ovary cells. Br J Cancer 64: 69-73, 1991.
103. Nagy E, Jeney V, Yachie A, Szabo RP, Wagner O, Vercel-lotti GM, Eaton JW, Balla G, and Balla J. Oxidation of hemoglobin by lipid hydroperoxide associated with LDL and increased cytotoxic effect by LDL oxidation in heme oxygenase-1 deficiency. Cell Mol Bio (Noisy-le-grand) 51: 377-385, 2005. (Pubitemid 41596315)
104. Nath KA, Grande JP, Haggard JJ, Croatt AJ, Katusic ZS, Solovey A, and Hebbel RP. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 158: 893-903, 2001. (Pubitemid 32221782)
105. Neil T, Abraham N, Levere R, and Kappas A. Differential heme oxygenase induction by stannous and stannic ions in the heart. J Cell Biochem 57: 409-414, 1995.
106. Nose K, Shibanuma M, Kikuchi K, Kageyama H, Sakiyama S, and Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteo-blastic cell line. Eur J Biochem 201: 99-106, 1991.
107. Ogawa K, Sun J, Taketani S, Nakajima O, Nishitani C, Sassa S, Hayashi N, Yamamoto M, Shibahara S, Fujita H, and Igarashi K. Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J 20: 2835-2843, 2001. (Pubitemid 32938566)
108. Omura T. Heme-thiolate proteins. Biochem Biophys Res Commun 338: 404-409, 2005. (Pubitemid 41540582)
109. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, and Hebbel RP. Reperfusion injury pathophys-iology in sickle transgenic mice. Blood 96: 314-320, 2000. (Pubitemid 30456487)
110. Otterbein LE, Soares MP, Yamashita K, and Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455, 2003. (Pubitemid 36928103)
111. Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M, Yamamoto M, and Igarashi K. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 16: 6083-6095, 1996. (Pubitemid 26360968)
112. Ozono R. New biotechnological methods to reduce oxida-tive stress in the cardiovascular system: focusing on the bach1=heme oxygenase-1 pathway. Curr Pharm Biotechnol 7: 87-93, 2006. (Pubitemid 44110355)
113. Pace B, Shartava A, Pack-Mabien A, Mulekar M, Ardia A, and Goodman S. Effects of N-acetylcysteine on dense cell formation in sickle cell disease. Am J Hematol 73: 26-32, 2003. (Pubitemid 36504574)
114. Paoli M, Anderson BF, Baker HM, Morgan WT, Smith A, and Baker EN. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two [beta]-propeller domains. Nat Struct Mol Biol 6: 926-931, 1999. (Pubitemid 29463305)
115. Park JH, Ma L, Oshima T, Carter P, Coe L, Ma JW, Specian R, Grisham MB, Trimble CE, Hsia CJC, Liu JE, and Alexander JS. Polynitroxylated starch=TPL attenuates cachexia and increased epithelial permeability associated with TNBS colitis. Inflammation 26: 1-11, 2002. (Pubitemid 34228898)
116. Potter D, Chroneos ZC, Baynes JW, Sinclair PR, Gorman N, Liem HH, Muller-Eberhard U, and Thorpe SR. In vivo fate of hemopexin and heme-hemopexin complexes in the rat. Arch Biochem Biophys 300: 98-104, 1993. (Pubitemid 23225723)
117. Ryter SW, Alam J, and Choi AMK. Heme oxygenase-1= carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650, 2006.
118. Sadrzadeh SM and Eaton JW. Hemoglobin-mediated oxi-dant damage to the central nervous system requires endogenous ascorbate. J Clin Invest 82: 1510-1515, 1988. (Pubitemid 19007752)
119. Samuni A, Krishna CM, Mitchell JB, Collins CR, and Russo A. Superoxide reaction with nitroxides. Free Radic Res 9: 241-249, 1990. (Pubitemid 20376777)
120. Schaer CA, Schoedon G, Imhof A, Kurrer MO, and Schaer DJ. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macro-phages to hemoglobin. Circ Res 99: 943-950, 2006. (Pubitemid 44657797)
121. Schaer DJ, Alayash AI, and Buehler PW. Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor. Antioxid Redox Signal 9: 991-999, 2007. (Pubitemid 46919600)
122. Schaer DJ, Schaer CA, Buehler PW, Boykins RA, Schoedon G, Alayash AI, and Schaffner A. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107: 373-380, 2006. (Pubitemid 43053566)
123. Setty BN and Stuart MJ. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 88: 2311-2320, 1996. (Pubitemid 26307936)
124. Shan Y, Lambrecht RW, and Bonkovsky HL. Identification of key elements that are responsible for heme-mediated induction of the avian heme oxygenase-1 gene. Biochim Biophys Acta 1679: 87-94, 2004. (Pubitemid 39024599)
125. Shan Y, Lambrecht RW, Ghaziani T, Donohue SE, and Bonkovsky HL. Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells: insights from studies with small interfering RNAs. J Biol Chem 279: 51769-51774, 2004. (Pubitemid 39656543)
126. Smith A. Links between cell-surface events involving redox-active copper and gene regulation in the hemopexin heme transport system. Antioxid Redox Signal 2: 157-175, 2000. (Pubitemid 30445930)
127. Smith A and Morgan WT. Haem transport to the liver by haemopexin: receptor-mediated uptake with recycling of the protein. Biochem J 182: 47-54, 1979. (Pubitemid 9240663)
128. Sugishima M, Omata Y, Kakuta Y, Sakamoto H, Noguchi M, and Fukuyama K. Crystal structure of rat heme oxygenase-1 in complex with heme. FEBS Lett 471: 61-66, 2000. (Pubitemid 30173293)
129. Sun J, Brand M, Zenke Y, Tashiro S, Groudine M, and Ig-arashi K. Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci USA 101: 1461-1466, 2004. (Pubitemid 38234177)
130. Suzuki H, Tashiro S, Sun J, Doi H, Satomi S, and Igarashi K. Cadmium induces nuclear export of bach1, a transcrip-tional repressor of heme oxygenase-1 gene. J Biol Chem 278: 49246-49253, 2003.
131. Tacchini L, Dansi P, Matteucci E, and Desiderio MA. He-patocyte growth factor signalling stimulates hypoxia in-ducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22: 1363-1371, 2001. (Pubitemid 32898691)
132. Tahara T, Sun J, Nakanishi K, Yamamoto M, Mori H, Saito T, Fujita H, Igarashi K, and Taketani S. Heme positively regulates the expression of {beta}-globin at the locus control region via the transcriptional factor bach1 in erythroid cells. J Biol Chem 279: 5480-5487, 2004. (Pubitemid 38220572)
133. Takahashi, K, Hara E, Suzuki H, Sasano H, and Shibahara S. Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors. J Neurochem 67: 482-489, 1996. (Pubitemid 26255640)
134. Taketani S, Kohno H, Tokunaga R, Ishii T, and Bannai S. Selenium antagonizes the induction of human heme oxy-genase by arsenite and cadmium ions. Biochem Int 23: 625-632, 1991.
135. Taketani S, Kohno H, Yoshinaga T, and Tokunaga R. Induction of heme oxygenase in rat hepatoma cells by exposure to heavy metals and hyperthermia. Biochem Int 17: 665-672, 1988 (Pubitemid 18267767)
136. 2 in endothelial cells. Am J Physiol Heart Circ Physiol 276: H1493-H1501, 1999. (Pubitemid 29246534)
137. Theil E. The ferritin family of iron storage proteins. Adv Enzymol Relat Areas Mol Biol 63: 421-449, 1990.
138. Thomas CE and Aust SD. Reductive release of iron from ferritin by cation free radicals of paraquat and other bi-pyridyls. J Biol Chem 261: 13064-13070, 1986. (Pubitemid 17006876)
139. Thomas CE, Morehouse LA, and Aust SD. Ferritin and superoxide-dependent lipid peroxidation. J Biol Chem 260: 3275-3280, 1985. (Pubitemid 15115239)
140. Tolosano E and Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol 21: 297-306, 2002. (Pubitemid 34594543)
141. Tsiftsoglou AS, Tsamadou AI, and Papadopoulou LC. Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther 111: 327-345, 2006. (Pubitemid 43832008)
142. Turhan A, Weiss LA, Mohandas N, Coller BS, and Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci USA 99: 3047-3051, 2002. (Pubitemid 34240583)
143. Tyrrell R. Redox regulation and oxidant activation of heme oxygenase-1. Free Radic Res 31: 335-340, 1999. (Pubitemid 29452859)
144. Vinchi F, Gastaldi S, Silengo L, Altruda F, and Tolosano E. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload. Am J Pathol 173: 289-299, 2008. (Pubitemid 351947975)
145. Wagener FA, Abraham NG, van Kooyk Y, de Witte T, and Figdor CG. Heme-induced cell adhesion in the pathogen-esis of sickle-cell disease and inflammation. Trends Pharmacol Sci 22: 52-54, 2001. (Pubitemid 32146473)
146. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, and Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood 98: 1802-1811, 2001.
147. Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, and Figdor CG. Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55: 551-571, 2003. (Pubitemid 37013215)
148. Willis D. Expression and modulatory effects of heme oxy-genase in acute inflammation in the rat. Inflamm Res 44: S218-S220, 1995.
149. Wood KC, Hebbel RP, and Granger DN. Endothelial cell P-selectin mediates a proinflammatory and prothrombo-genic phenotype in cerebral venules of sickle cell transgenic mice. Am J Physiol Heart Circ Physiol 286: H1608-H1614, 2004. (Pubitemid 38525445)
150. Wu L and Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 57: 585-630, 2005. (Pubitemid 43036442)
151. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129-135, 1999. (Pubitemid 29031171)
152. Yang Z-Z and Zou A-P. Transcriptional regulation of heme oxygenases by HIF-1alpha in renal medullary interstitial cells. Am J Physiol Renal Physiol 281: F900-F908, 2001.
153. Yano Y, Ozono R, Oishi Y, Kambe M, Yoshizumi M, Ishida T, Omura S, Oshima T, and Igarashi K. Genetic ablation of the transcription repressor Bach1 leads to myocardial protection against ischemia=reperfusion in mice. Genes Cells 11: 791-803, 2006. (Pubitemid 43923350)
154. Yonghong Y, Ohta K, Shimizu M, Morimoto K, Goto C, Nakai A, Toma T, Kasahara Y, Yachie A, Seki H, and Koizumi S. Selective protection of renal tubular epithelial cells by heme oxygenase (HO)-1 during stress-induced injury. Kidney Int 64: 1302-1309, 2003. (Pubitemid 37153795)
155. Zhao G, Bou-Abdallah F, Yang X, Arosio P, and Chasteen ND. Is hydrogen peroxide produced during iron(ii) oxidation in mammalian apoferritins? Biochemistry 40: 10832-10838, 2001. (Pubitemid 32835025)
156. ZimaAVand Blatter LA. Redox regulationofcardiac calcium channels and transporters. Cardiovasc Res 71: 310-321, 2006.